• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西方中心对肝门周围胆管癌的外科治疗的演变表明,内镜胆道引流术可提高生存率,减少输血的使用。

Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion.

机构信息

Department of Hepatobiliary and Transplant Surgery, St James's University Hospital, Leeds, UK.

出版信息

HPB (Oxford). 2011 Jul;13(7):483-93. doi: 10.1111/j.1477-2574.2011.00328.x.

DOI:10.1111/j.1477-2574.2011.00328.x
PMID:21689232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3133715/
Abstract

BACKGROUND

Perihilar cholangiocarcinoma (PHCCA) remains a surgical challenge for which few large Western series have been reported. The aims of this study were to investigate the results of surgical resection for PHCCA and assess how practice has evolved over the past 15 years.

METHODS

A prospectively maintained database was interrogated to identify all resections. Clinicopathological data were analysed for impact on survival. Subsequently, data for resections carried out during the periods 1994-1998, 1999-2003 and 2004-2008 were compared.

RESULTS

Eighty-three patients underwent resection. Trisectionectomy was required in 67% of resections. Overall survival was 70%, 36% and 20% at 1, 3 and 5 years, respectively. Size of tumour, margin (R0) status, lymph node status, distant metastasis, tumour grade, portal vein resection, microscopic direct vascular invasion, T-stage and blood transfusion requirement significantly affected outcome on univariate analysis. Distant metastasis (P = 0.040), percutaneous biliary drainage (P = 0.015) and blood transfusion requirement (P = 0.026) were significant factors on multivariate analysis. Survival outcomes improved and blood transfusion requirement was significantly reduced in the most recent time period.

DISCUSSION

Blood transfusion requirement and preoperative percutaneous biliary drainage were identified as independent indicators of a poor prognosis following resection of PHCCA. Longterm survival can be achieved following the aggressive surgical resection of this tumour, but the emergence of a clear learning curve in our analyses indicates that these patients should be managed in high-volume centres in order to achieve improved outcomes.

摘要

背景

肝门部胆管癌(PHCCA)仍然是一个手术挑战,目前仅有少数西方大系列报道。本研究的目的是探讨手术切除 PHCCA 的结果,并评估过去 15 年来实践的演变。

方法

通过前瞻性维护的数据库来确定所有的手术。分析临床病理数据对生存的影响。随后,比较了 1994-1998 年、1999-2003 年和 2004-2008 年期间进行的手术数据。

结果

83 例患者接受了切除术。67%的切除术需要进行三叶切除术。1、3、5 年的总生存率分别为 70%、36%和 20%。肿瘤大小、切缘(R0)状态、淋巴结状态、远处转移、肿瘤分级、门静脉切除、显微镜下直接血管侵犯、T 分期和输血需求在单因素分析中显著影响结果。多因素分析显示,远处转移(P=0.040)、经皮胆道引流(P=0.015)和输血需求(P=0.026)是显著因素。在最近的时间段,生存结果得到改善,输血需求显著减少。

讨论

输血需求和术前经皮胆道引流被确定为 PHCCA 切除后预后不良的独立指标。虽然通过积极的手术切除可以实现长期生存,但我们分析中的明确学习曲线表明,这些患者应该在高容量中心进行管理,以实现更好的结果。

相似文献

1
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion.西方中心对肝门周围胆管癌的外科治疗的演变表明,内镜胆道引流术可提高生存率,减少输血的使用。
HPB (Oxford). 2011 Jul;13(7):483-93. doi: 10.1111/j.1477-2574.2011.00328.x.
2
Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.肝门部胆管癌手术的进展显示预后改善:一项单中心分析
Tumori. 2014 Nov-Dec;100(6):e250-6. doi: 10.1700/1778.19288.
3
Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.经皮胆道引流与内镜引流在肿瘤学方面劣势的验证:可切除肝门部胆管癌的倾向评分匹配分析
Surgery. 2017 Feb;161(2):394-404. doi: 10.1016/j.surg.2016.08.008. Epub 2016 Oct 4.
4
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
5
Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.左三叶切除术治疗肝门周围胆管癌的临床意义:评价及与左半肝切除术的比较。
Ann Surg. 2012 Apr;255(4):754-62. doi: 10.1097/SLA.0b013e31824a8d82.
6
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
7
Surgical resection for hilar cholangiocarcinoma: experience improves resectability.肝门部胆管癌的外科切除术:经验可提高可切除性。
HPB (Oxford). 2012 Feb;14(2):142-9. doi: 10.1111/j.1477-2574.2011.00419.x. Epub 2011 Dec 12.
8
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
9
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.对肝门部胆管癌进行的连续102例肝胆切除术,死亡率为零。
Ann Surg. 2006 Aug;244(2):240-7. doi: 10.1097/01.sla.0000217605.66519.38.
10
Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.肝门部胆管癌患者术前内镜下胆道引流的肿瘤学获益
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):533-40. doi: 10.1002/jhbp.76. Epub 2014 Jan 27.

引用本文的文献

1
Perihilar cholangiocarcinoma: a surgeon's perspective.肝门部胆管癌:外科医生的视角
ILIVER. 2022 Apr 5;1(1):12-24. doi: 10.1016/j.iliver.2022.03.004. eCollection 2022 Mar.
2
Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.肝门部胆管癌可切除性的三维可视化评估与新分类方法的提出
World J Surg Oncol. 2023 Aug 5;21(1):239. doi: 10.1186/s12957-023-03126-2.
3
Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: .围手术期输血对接受根治性切除的不同分期肝门部胆管癌患者长期生存的影响:
Front Oncol. 2022 Oct 31;12:1059581. doi: 10.3389/fonc.2022.1059581. eCollection 2022.
4
Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma.肝门部胆管癌治疗后手术及肿瘤学结局的时间顺序分析
Ann Hepatobiliary Pancreat Surg. 2021 Feb 28;25(1):62-70. doi: 10.14701/ahbps.2021.25.1.62.
5
Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.肝门部胆管癌伴血管侵犯的手术治疗结果。
J Gastrointest Surg. 2019 Jul;23(7):1443-1453. doi: 10.1007/s11605-018-3948-x. Epub 2018 Sep 10.
6
ENBD is Associated with Decreased Tumor Dissemination Compared to PTBD in Perihilar Cholangiocarcinoma.ENBD 与 PTBD 相比,可减少肝门部胆管癌的肿瘤播散。
J Gastrointest Surg. 2017 Sep;21(9):1506-1514. doi: 10.1007/s11605-017-3492-0. Epub 2017 Jul 18.
7
Cholangiocarcinoma: Current Knowledge and New Developments.胆管癌:当前认知与新进展
Gut Liver. 2017 Jan 15;11(1):13-26. doi: 10.5009/gnl15568.
8
Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.围手术期输血与肝门部胆管癌切除术后的总生存期或复发时间无关。
HPB (Oxford). 2016 Mar;18(3):262-70. doi: 10.1016/j.hpb.2015.08.004. Epub 2016 Jan 6.
9
Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.肝门部胆管癌患者行肝胆切除术后基于炎症的预后评分评估
J Gastroenterol. 2016 Feb;51(2):153-61. doi: 10.1007/s00535-015-1103-y. Epub 2015 Jul 18.
10
Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution.肝门部胆管癌手术疗效的改善:基于单一机构40年经验的手术方式变化及相关结果
Surg Today. 2016 Jan;46(1):74-83. doi: 10.1007/s00595-015-1119-1. Epub 2015 Feb 5.

本文引用的文献

1
Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma.经皮经肝胆管引流导管通路复发的胆管癌。
Br J Surg. 2010 Dec;97(12):1860-6. doi: 10.1002/bjs.7228. Epub 2010 Aug 26.
2
Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma.内镜鼻胆管引流术是治疗肝门部胆管癌患者最适合的术前胆道引流方法。
J Gastroenterol. 2011 Feb;46(2):242-8. doi: 10.1007/s00535-010-0298-1. Epub 2010 Aug 11.
3
Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis.肝切除术治疗结直肠肝转移术后感染性并发症与长期预后的相关性。
Ann Surg. 2010 Jan;251(1):91-100. doi: 10.1097/SLA.0b013e3181bfda3c.
4
Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience.肝门部胆管癌的外科治疗:“新时代”的名古屋大学经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):449-54. doi: 10.1007/s00534-009-0209-0. Epub 2009 Oct 6.
5
Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.肝门部胆管癌切缘阳性近端胆管附加切除的临床价值。
Surgery. 2010 Jan;147(1):49-56. doi: 10.1016/j.surg.2009.06.030. Epub 2009 Sep 20.
6
Hilar cholangiocarcinoma: current management.肝门部胆管癌:当前的治疗方法
Ann Surg. 2009 Aug;250(2):210-8. doi: 10.1097/SLA.0b013e3181afe0ab.
7
The concept of perihilar cholangiocarcinoma is valid.肝门周围胆管癌的概念是有效的。
Br J Surg. 2009 Aug;96(8):926-34. doi: 10.1002/bjs.6655.
8
Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.基于吉西他滨的辅助化疗可提高肝门部胆管癌根治性手术后的生存率。
J Gastrointest Surg. 2009 Aug;13(8):1470-9. doi: 10.1007/s11605-009-0900-0. Epub 2009 May 7.
9
Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma.门静脉动脉化作为肝门部胆管癌左半肝三叶切除术中的一种挽救性手术。
J Am Coll Surg. 2008 Nov;207(5):e1-6. doi: 10.1016/j.jamcollsurg.2008.07.019. Epub 2008 Aug 30.
10
Preoperative biliary drainage before resection for cholangiocarcinoma (Pro).术前胆管引流在胆管癌切除术前(Pro)。
HPB (Oxford). 2008;10(2):130-3. doi: 10.1080/13651820801992666.